Clinical Trials Browser

Phase 1 × Lymphoma, Large B-Cell, Diffuse × Alemtuzumab × Clear all

NCT03132584 2019-01-14

Cyclophosphamide and Alemtuzumab In Lymphoma

Phase 1 Terminated

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse